Navigation Links
Lancet Urges To Allow Emergency Contraception Drug As An OTC

The U.S. Food and Drug Administration authority is under pressure as it has been urged to make emergency contraception drug as an over-the counter drug//.

Andrew von Eschenbach, acting Commissioner of the FDA has been urged to take an independent, non-biased decision on Barr Pharmaceuticals Inc's bid to sell its morning after pill or Plan B without a medical prescription.

Plan B consists of a set of two pills that can prevent pregnancy if taken within 72 hours of unprotected intercourse. The action of this pill is in much contrast to the abortion pill RU-486 that terminates an established pregnancy.

The Lancet is an internationally acclaimed medical journal. Editors of this prestigious journal, ‘the agency is stalling, apparently to avoid offending antiabortion supporters of President Bush.’

Earlier this year, Andrew von Eschenbach was tapped by the President to run the agency, fulltime. However, the nomination has been stalled in the U.S. Senate. Critics argue that approval of this Plan B drug to be sold over the counter may actualy

Page: 1

Related medicine news :

1. Lancet Blames CMA For Dismissal Of Editors
2. The Lancet Calls For Review Of Regulatory Process Of Drug Trials
3. President Bush Urges Citizens to Invest In Health Savings Account (HSAs)
4. Minister Of State For Industry Urges Corporate Sectors To Help Indias Disabled Population
5. Minister of State For Industry Urges Corporate Sectors to help India’s Disabled Populatio
6. Ramadoss Urges Celebrities to Stay Away From Soft Drink Ads
7. Ramadoss Urges Celebrities Not To Endorse Soft Drinks
8. Make Medicines Affordable: Jamir Urges Pharma Companies
9. Disabled Girl Urges Kalam to Intervene Against the Denial of Admission
10. Keep Australias GP Workforce Numbers Healthy, AMA Urges
11. AMA Urges Doctors to be Upfront about Fees
Post Your Comments:

(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: